William B. Messer

Oregon Health & Science University — United States

Medicine · Health Sciences

31h-index4.7kcitations143works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mosquito-borne diseases and control(54), SARS-CoV-2 and COVID-19 Research(39), Viral Infections and Vectors(36), COVID-19 Clinical Research Studies(33), Malaria Research and Control(16)

Publications138 total

Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
Communications Medicine·2026Open Access
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study.
PubMed·2025Open Access
Update on emerging and re-emerging vector-borne diseases
The American Journal of the Medical Sciences·2025
Endothelial leak and knowledge gaps: yellow fever virus non-structural protein 1 and the antibodies that bind it
Virology Journal·2025· 1 citedOpen Access
Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDS
Critical Care·2025· 1 citedOpen Access
A multiomics recovery factor predicts long COVID in the IMPACC study
Journal of Clinical Investigation·2025· 1 citedOpen Access
Dengue virus infection reprograms baseline innate immune gene expression
Med·2025· 2 cited
New insights into an old vaccine: potency and breadth of neutralizing antibodies elicited by the yellow fever vaccine 17D are boosted by heterologous <i>Orthoflavivirus</i> infection
2025Open Access
Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study
Frontiers in Medicine·2025Open Access
MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injury
JCI Insight·2025· 1 citedOpen Access
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit
2025Open Access
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohort
Journal of Allergy and Clinical Immunology Global·2025· 1 citedOpen Access
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19
JCI Insight·2025· 1 citedOpen Access
Identification of a multi-omics factor predictive of long COVID in the IMPACC study
2025Open Access
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
2025· 1 citedOpen Access
Association of high γ′ fibrinogen levels with adverse events in patients with COVID-19
Blood Vessels Thrombosis & Hemostasis·2025· 1 citedOpen Access
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients
Nature Communications·2025· 4 citedOpen Access
The alphavirus determinants of intercellular long extension formation
mBio·2024· 3 citedOpen Access
Long-Term Immunity after Vaccination against Yellow Fever in Korean Travelers
Japanese Journal of Infectious Diseases·2024· 1 citedOpen Access
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular Subtyping
2024· 2 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Zoë L. Lyski(14), Aravinda M. de Silva(12), Fikadu Tafesse(12), Hans C. Leier(9), Marcel E. Curlin(9), Timothy A. Bates(8), Ralph S. Baric(7), David X. Lee(7), Savannah K. McBride(6), Catherine L. Hough(6), Ofer Levy(6), Al Ozonoff(6), Jeremy Huynh(5), Michael Denton(5), Daniel N. Streblow(5), Jules B. Weinstein(5), Amanda E. Brunton(5), Boyd L. Yount(5), Ruth R. Montgomery(5), Steven H. Kleinstein(5)